Stay updated on Nivolumab Post-chemoradiotherapy Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Post-chemoradiotherapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Post-chemoradiotherapy Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page has been updated to a newer ClinicalTrials.gov revision version (v3.5.3 instead of v3.5.2), reflecting a site update rather than any change to the underlying study information.
    Difference
    0.1%
    Check dated 2026-04-24T16:57:08.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Ono Pharmaceutical Co., Ltd. is added as a collaborator with the standardized company name. The page revision is updated to v3.5.2, replacing the previous Ono Pharmaceutical Co. Ltd and revision v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T13:38:35.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T21:05:32.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T19:49:34.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    The site revision label in the footer was updated from v3.4.1 to v3.4.2.
    Difference
    0.1%
    Check dated 2026-02-12T01:49:56.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    The update adds Revision: v3.4.1 and removes Revision: v3.4.0, indicating a metadata version change rather than changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:41:47.000Z thumbnail image

Stay in the know with updates to Nivolumab Post-chemoradiotherapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Post-chemoradiotherapy Clinical Trial page.